PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN
Abstract
Authors
A Shearer A Bagust FJ Ampudia-Blasco MJ TaylorJ S Mendes da Costa